CrushSCI.com
Journal Selection & Manuscript Polishing Services
Clinical Colorectal Cancer journal cover Medicine
Back to journal directory

Review Cycle Records

Clinical Colorectal Cancer

Elsevier SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
178.6Average days
160.5Median days
46Fastest days
431Longest days
652025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

83 days

Application of a Domestic Chinese Robotic Surgical System in Radical Resection Combined With Lateral Lymph Node Dissection for Low Rectal Cancer: A Retrospective Study

AuthorsFeng Zheng; Aihe Sun; Peng Zhai; Zhongming Bao; Yongjun Jiang

AffiliationsDepartment of General Surgery, The Fifth People’s Hospital of Huai’an (Huai’an Hospital Affiliated to Yangzhou University), Huai’an, PR China

Source PDF DOI Publisher page
238 days

Colorectal Cancer Screening at Younger Ages: A Multicutoff Analysis of FIT Performance

AuthorsJulia Hibbert; Teresa Seum; Michael Hoffmeister; Hermann Brenner

AffiliationsDivision of Clinical Epidemiology of Early Cancer Detection, German Cancer Research Center (DKFZ), Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; Cancer Prevention Graduate School, German Cancer Research Center (DKFZ), Heidelberg, Germany

Source PDF DOI Publisher page
77 days

Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study

AuthorsIlaria Prata; Iris D. Nagtegaal; Geke Hospers; Johannes H.W. de Wilt; Cristina Graham Martinez; Stefan A.J. Hutschemaekers; Steven Vanhoutvin; Annemieke Cats; Corrie A.M. Marijnen

AffiliationsGROW, School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Radiation Oncology, Haaglanden Medisch Centrum, Leidschendam, the Netherlands; HollandPTC, Delft, the Netherlands; Trial and Data Center, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands

Source PDF DOI Publisher page
338 days

The Impact of Lesion Morphology and Resection Strategy on Curative Outcomes in Colorectal Malignant Polyps

AuthorsJoão C. Gonçalves; Ana I. Ferreira; Mariana Souto; Raquel Barros; Sofia Xavier; Pedro B. Carvalho; Joana Magalhães; José Cotter

AffiliationsGastroenterology Department, Unidade Local de Saúde do Alto Ave, Guimarães, Portugal; School of Medicine, Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal; Academic Centre, Unidade Local de Saúde do Alto Ave, Guimarães, Portugal

Source PDF DOI Publisher page
199 days

Prognostic Value of Liver Metastases and KRAS Mutations in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Third-Line Placebo-Controlled Trials From the ARCAD CRC Database

AuthorsThomas Samaille; Morteza Raeisi; Romain Cohen; Qian Shi; Takayuki Yoshino; John R. Zalcberg; Richard Adams; Chiara Cremolini; Axel Grothey; Robert J. Mayer; Benoist Chibaudel; Aimery de Gramont; Thierry André

AffiliationsDepartment of Medical Oncology, Sorbonne University, Saint-Antoine Hospital, AP-HP, Paris, France; Statistical Unit, ARCAD Foundation, Paris, France; Department of Quantitative Health Science, Mayo Clinic, Rochester, NY; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Monash University, School of Public Health and Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia; Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom; Department of Translational Research and New Technologies, University of Pisa, Pisa, Italy; West Cancer Center, Germantown, TN; Dana-Farber Cancer Institute, Boston, MA; Department of Medical Oncology, Franco-British Hospital, Fondation Cognacq-Jay, Levallois-Perret, France; ARCAD Foundation, Paris, France

Source PDF DOI Publisher page
128 days

Dual CTLA-4/PD-1 Blockade Versus Anti–PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors

AuthorsLea Jehanno; Julie Henriques; Thomas Samaille; Camille Loisel; Baptiste Cervantes; Raphaël Colle; Dewi Vernerey; Thierry André; Romain Cohen

AffiliationsSorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; EFS, Université Marie et Louis Pasteur, Besançon, France; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France; Sorbonne University, INSERM, Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France

Source PDF DOI Publisher page
46 days

Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon

AuthorsYuji Takayama; Kosuke Ichida; Taro Fukui; Nao Kakizawa; Fumiaki Watanabe; Koichi Suzuki; Toshiki Rikiyama

AffiliationsDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan

Source PDF DOI Publisher page
53 days

Fruquintinib or Regorafenib? A Weighted Toxicity Score Analysis to Facilitate Better Discussions on Toxicity and Benefits in Later-line Colorectal Cancer Treatment

AuthorsSalvatore Corallo; Francesco Agustoni; Anna Pagani; Francesco Serra; Alessandra Ferrari; Nicola Personeni; Paolo Pedrazzoli; Chiara Citterio

AffiliationsDepartment of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy; Department of Oncology, Comprehensive Cancer Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy; Medical Oncology Unit, AUSL Piacenza, Piacenza, Italy; UOC Innovation, Research and Quality, AUSL Piacenza, Piacenza, Italy

Source PDF DOI Publisher page
193 days

Detection of Polyps in Colon Capsule Endoscopy and Impact of Colonic Transit Time

AuthorsOla Selnes; Lea Østergaard Hansen; Benedicte Schelde-Olesen; Thomas Bjørsum-Meyer; Lasse Kaalby; Anastasios Koulaouzidis; Gunnar Baatrup; Ulrik Deding

AffiliationsDepartment of Surgery, Odense University Hospital, Svendborg, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland

Source PDF DOI Publisher page
431 days

Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer

AuthorsLisa Salvatore; Marwan Fakih; Yasutoshi Kuboki; David S. Hong; Dominik Paul Modest; Julien Taieb; Timothy Jay Price; Chiara Cremolini; Istvan Matyas Majer; Marko Rehn; Emily Chan; Ziyan Chen; Qui Tran; Filippo Pietrantonio

AffiliationsOncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli–IRCCS, Rome, Italy; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, University of Texas, Houston, TX; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, Université Paris-Cité, SIRIC CARPEM, Paris, France; Queen Elizabeth Hospital, University of Adelaide, Adelaide, SA, Australia; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; Health Economics and Outcomes Research, Amgen (Europe) GmbH, Rotkreuz, Switzerland; Global Medical Organization, Amgen Inc., Thousand Oaks, CA; Global Development, Amgen Inc., Thousand Oaks, CA; Health Economic and Outcomes Research, Amgen Inc., Tampa, FL; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.